NASDAQ: PRME
Prime Medicine Inc Stock Ownership - Who owns Prime Medicine?

Insider buying vs selling

Have Prime Medicine Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gv 2021 GP LLC10% Owner2025-08-011,500,000$3.30
$4.95MBuy
Arch Venture Partners X LLC10% Owner2025-08-013,030,300$3.30
$10.00MBuy
Robert NelsenDirector2025-08-013,030,300$3.30
$10.00MBuy
Arch Venture Partners XII LLC10% Owner2025-08-013,030,300$3.30
$10.00MBuy
David R. Liu10% Owner2025-06-3021,000$2.52
$52.84kBuy
David R. Liu10% Owner2025-06-2321,000$2.16
$45.40kBuy
David R. Liu10% Owner2025-06-1621,000$1.49
$31.21kBuy
David R. Liu10% Owner2025-06-1121,000$1.60
$33.58kBuy
Ann L. LeeChief Technical Officer2025-05-21100,000$1.13
$113.00kBuy
Allan ReineChief Executive Officer2025-05-21125,000$1.18
$147.13kBuy

1 of 2

PRME insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PRME insiders and whales buy or sell their stock.

PRME Shareholders

What type of owners hold Prime Medicine Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
David R. Liu15.42%20,240,945$65.58MInsider
Robert Nelsen14.09%18,502,974$59.95MInsider
Arch Venture Partners XII LLC14.08%18,486,894$59.90MInsider
Arch Venture Partners X LLC14.08%18,486,894$59.90MInsider
Alphabet Inc11.47%15,062,498$48.80MInstitution
Gv 2019 GP LLC9.04%11,862,498$38.43MInsider
Fmr LLC6.45%8,462,946$27.42MInsider
T Rowe Price Investment Management Inc4.94%6,484,787$21.01MInstitution
Keith Michael Gottesdiener4.15%5,451,894$17.66MInsider
Thomas Cahill4.04%5,305,679$17.19MInsider

1 of 3

PRME vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PRME33.86%66.14%Net BuyingNet Buying
LXRX21.70%78.30%Net Selling
INBX71.68%28.32%Net Buying
NBTX11.90%0.00%
XOMA18.69%81.31%Net SellingNet Buying

Prime Medicine Stock Ownership FAQ

Who owns Prime Medicine?

Prime Medicine (NASDAQ: PRME) is owned by 44.71% institutional shareholders, 87.32% Prime Medicine insiders, and 0.00% retail investors. David R. Liu is the largest individual Prime Medicine shareholder, owning 20.24M shares representing 15.42% of the company. David R. Liu's Prime Medicine shares are currently valued at $63.15M.

If you're new to stock investing, here's how to buy Prime Medicine stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.